Works by Kominami, Ryota

Results: 7

Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab.

Published in:

2020

By:

Morita, Mitsunori;
Tamiya, Motohiro;
Fujimoto, Daichi;
Tamiya, Akihiro;
Suzuki, Hidekazu;
Hirano, Katsuya;
Fukuda, Yasushi;
Yokoyama, Toshihide;
Kominami, Ryota;
Kanazu, Masaki;
Uchida, Junji;
Hara, Satoshi;
Yamashita, Shuji;
Tomioka, Hiromi

Publication type:

journal article

Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.

Published in:

2020

By:

Hosoya, Kazutaka;
Fujimoto, Daichi;
Morimoto, Takeshi;
Kumagai, Toru;
Tamiya, Akihiro;
Taniguchi, Yoshihiko;
Yokoyama, Toshihide;
Ishida, Tadashi;
Hirano, Katsuya;
Matsumoto, Hirotaka;
Kominami, Ryota;
Tomii, Keisuke;
Suzuki, Hidekazu;
Hirashima, Tomonori;
Uchida, Junji;
Morita, Mitsunori;
Kanazu, Masaki;
Sawa, Nobuhiko;
Makio, Takeshi;
Hara, Satoshi

Publication type:

journal article

Experimental study on open-end correction of a Helmholtz resonator narrow slit neck.

Published in:

Noise Control Engineering Journal, 2022, v. 70, n. 2, p. 128, doi. 10.3397/1/377011

By:

Shuichi Sakamoto;
Yuki Akiba;
Ryo Iizuka;
Shunsuke Watanabe;
Ryota Kominami;
Tetsushi Shintani

Publication type:

Article

Small plate vibration sound-absorbing device with a clearance and without surrounding restriction: Theoretical analysis and experiment.

Published in:

Noise Control Engineering Journal, 2021, v. 69, n. 1, p. 30, doi. 10.3397/1/37693

By:

Shuichi Sakamoto;
Kouhei Fujisawa;
Shunsuke Watanabe;
Taku Watanabe;
Ryota Kominami;
Yuki Akiba

Publication type:

Article

Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non–small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study.

Published in:

Investigational New Drugs, 2020, v. 38, n. 1, p. 211, doi. 10.1007/s10637-019-00882-5

By:

Kawachi, Hayato;
Tamiya, Motohiro;
Tamiya, Akihiro;
Ishii, Seigo;
Hirano, Katsuya;
Matsumoto, Hirotaka;
Fukuda, Yasushi;
Yokoyama, Toshihide;
Kominami, Ryota;
Fujimoto, Daichi;
Hosoya, Kazutaka;
Suzuki, Hidekazu;
Hirashima, Tomonori;
Kanazu, Masaki;
Sawa, Nobuhiko;
Uchida, Junji;
Morita, Mitsunori;
Makio, Takeshi;
Hara, Satoshi;
Kumagai, Toru

Publication type:

Article

Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1266, doi. 10.1007/s10637-019-00843-y

By:

Tamiya, Motohiro;
Tamiya, Akihiro;
Hosoya, Kazutaka;
Taniguchi, Yoshihiko;
Yokoyama, Toshihide;
Fukuda, Yasushi;
Hirano, Katsuya;
Matsumoto, Hirotaka;
Kominami, Ryota;
Suzuki, Hidekazu;
Hirashima, Tomonori;
Uchida, Junji;
Morita, Mitsunori;
Kanazu, Masaki;
Sawa, Nobuhiko;
Kinoshita, Yoshinori;
Hara, Satoshi;
Kumagai, Toru;
Fujimoto, Daichi

Publication type:

Article

Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study.

Published in:

2021

By:

Hosoya, Kazutaka;
Fujimoto, Daichi;
Morimoto, Takeshi;
Kumagai, Toru;
Tamiya, Akihiro;
Taniguchi, Yoshihiko;
Yokoyama, Toshihide;
Ishida, Tadashi;
Matsumoto, Hirotaka;
Hirano, Katsuya;
Kominami, Ryota;
Tomii, Keisuke;
Suzuki, Hidekazu;
Hirashima, Tomonori;
Tanaka, Satoshi;
Uchida, Junji;
Morita, Mitsunori;
Kanazu, Masaki;
Mori, Masahide;
Nagata, Kenji

Publication type:

journal article